Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02279082 · ClinicalTrials.gov registry record · Phase 3
DFN-02 Open Label Safety Study in Patients With Acute Migraine
A Phase 3 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 3
- Development phase
- 167
- Enrollment target
NCT02279082 is a Phase 3 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 167 participants.
The verdict
NCT02279082, a Phase 3 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 167 participants
- Enrollment target
Study Summary
A multi-center, open-label, safety study of DFN-02 for the Treatment of Acute Migraines
Interventions
- DRUG DFN-02
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02279082
The ClinicalTrials.gov registry entry for NCT02279082 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DFN-02 is the first listed.
NCT02279082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02279082 about?
NCT02279082 is a clinical study titled "DFN-02 Open Label Safety Study in Patients With Acute Migraine". A multi-center, open-label, safety study of DFN-02 for the Treatment of Acute Migraines
What is the current status of trial NCT02279082?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 167 participants. The study started on 2014-09. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02279082?
The interventions under investigation include: DFN-02 (DRUG).
Who is sponsoring clinical trial NCT02279082?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.